Premium Stocks (>₹1000) — Price Based stock screen for NSE and BSE companies
High-priced stocks trading above ₹1000 per share The screen evaluates price based criteria across quarterly consolidated filings and surfaces Price, P/E, Market cap, 52W high for every matching company, alongside price, market capitalisation and valuation context.
Results are rebuilt from quarterly filings: anchor to a reporting period with the period control, switch between a focused metric view and the full column set, sort any column, and follow each symbol into its company page for statements, shareholding history and ratio analysis.
The methodology, column definitions and analysis guidelines on this page are free to read; the live results table is a JustTicks premium feature. Screening output is a research starting point — verify the underlying filings before acting, since a company can pass numerical filters while carrying risks the selected metrics never capture.
What does the Premium Stocks (>₹1000) screener identify?
High-priced stocks trading above ₹1000 per share The screen ranks matching companies on Price, P/E, Market cap, 52W high using quarterly consolidated filings, with every row linking to the company's full fundamentals workspace.
How often is the Premium Stocks (>₹1000) screener updated?
The underlying data refreshes with quarterly shareholding and fundamental filings. A reporting-period control lets you anchor results to the latest quarter or compare earlier windows, and the reporting basis is consolidated.
Is the Premium Stocks (>₹1000) screener free to use?
The methodology, metric definitions and analysis guide on this page are free to read. The live results table requires a JustTicks premium subscription — this screen is classified as a technical, medium-risk strategy.
Related JustTicks tools: All fundamental screeners, Stocks Below ₹100, Stocks Below ₹50, 52-Week High Performers
Premium Stocks (>₹1000)
High-priced stocks trading above ₹1000 per share
Checking subscription...
Understanding Price-Based Screening
High-priced stocks trading above ₹1000 per share Results are rebuilt from quarterly consolidated filings for NSE and BSE listed companies, with a reporting-period control to anchor or compare windows.
Key analysis points
- Price level doesn't indicate value or quality
- Stocks below ₹100 may be affordable but not necessarily cheap
- Premium stocks (>₹1000) may deserve high valuations
- 52-week high/low shows price range and momentum
- Breakouts from 52-week high can signal strong uptrends
Analysis guidelines
- Low price stocks often have higher volatility and risk
- High price doesn't mean overvalued - check fundamentals
- Stocks near 52-week high show positive momentum
- Stocks near 52-week low may be value opportunities or value traps
- Use price levels with other fundamental indicators
Pro tips
- Don't buy stocks just because price is 'low'
- 52-week high breakouts with volume are bullish signals
- Stocks making new highs often continue higher
- Consider position sizing for volatile low-price stocks
Frequently asked questions
Frequently asked questions
What does the Premium Stocks (>₹1000) screener identify?
High-priced stocks trading above ₹1000 per share The screen ranks matching companies on Price, P/E, Market cap, 52W high using quarterly consolidated filings, with every row linking to the company's full fundamentals workspace.
How often is the Premium Stocks (>₹1000) screener updated?
The underlying data refreshes with quarterly shareholding and fundamental filings. A reporting-period control lets you anchor results to the latest quarter or compare earlier windows, and the reporting basis is consolidated.
Is the Premium Stocks (>₹1000) screener free to use?
The methodology, metric definitions and analysis guide on this page are free to read. The live results table requires a JustTicks premium subscription — this screen is classified as a technical, medium-risk strategy.
For educational and informational purposes only — not investment advice. Data from quarterly consolidated filings (NSE/BSE); verify against exchange disclosures before acting.